TIMP-1 is under regulation of the EGF signaling axis and promotes an aggressive phenotype in KRAS-mutated colorectal cancer cells: a potential novel approach to the treatment of metastatic colorectal cancer.

Oncotarget · 2016 · PMC5312323 · PMID 27509063

Europe PMC DOI

hedged sentence

0.0590

closest p · 1.2× alpha

0.0590

boldest claim

The sentences

showed a trendP = 0.059so close (0.05 < p ≤ 0.1)

Multivariate analysis showed a trend for an association between RR and pre-treatment plasma TIMP-1 (OR, 1.34; 95% CI, 0.99 to 1.82; P = 0.059).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.